Real-World research study reveals less than half of NSCLC patients receive comprehensive biomarker testing prior to receiving 1st line therapy. CONTEXT: A retrospective chart review of metastatic NSCLC patients presented Continue Reading
CONTEXT: Report from ASCO 2021 from the MYLUNG Consortium research study in metastatic NSCLC. The findings based on the results from the first of 5 protocols is a retrospective review Continue Reading
CONTEXT: On the back of previous news stories about genetic biomarker testing in NSCLC, Neogenomics announces the launch of KRAS G12C testing to eligible advanced / late stage NSCLC cancer Continue Reading
CONTEXT: A little off our usual remit of RWR, but we think this kind of advancement in mental health warrants putting on our news site. Being able to use a Continue Reading
CONTEXT: Oncology news article on use of RWR in oncology. Nothing new in terms of data use, more confirmation of RWD in oncology research. However, an interesting perspective from the Continue Reading
